Andreas Güenther

5.4k total citations
92 papers, 3.4k citations indexed

About

Andreas Güenther is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Andreas Güenther has authored 92 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in Andreas Güenther's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Neonatal Respiratory Health Research (25 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Andreas Güenther is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Neonatal Respiratory Health Research (25 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Andreas Güenther collaborates with scholars based in Germany, United States and France. Andreas Güenther's co-authors include Werner Seeger, Philipp Markart, Martina Korfei, Clemens Ruppert, Poornima Mahavadi, Ingrid Henneke, Małgorzata Wygrecka, Ludger Fink, Klaus T. Preissner and Soni Savai Pullamsetti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Andreas Güenther

89 papers receiving 3.3k citations

Peers

Andreas Güenther
Clemens Ruppert Germany
Shwu‐Fan Ma United States
Dong‐Sheng Cheng United States
Naoki Hagimoto Japan
Marjukka Myllärniemi Finland
Brian B. Graham United States
Jean‐Jacques Lafitte France
William D. Hardie United States
Susan H. Guttentag United States
Leigh M. Marsh Austria
Clemens Ruppert Germany
Andreas Güenther
Citations per year, relative to Andreas Güenther Andreas Güenther (= 1×) peers Clemens Ruppert

Countries citing papers authored by Andreas Güenther

Since Specialization
Citations

This map shows the geographic impact of Andreas Güenther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Güenther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Güenther more than expected).

Fields of papers citing papers by Andreas Güenther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Güenther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Güenther. The network helps show where Andreas Güenther may publish in the future.

Co-authorship network of co-authors of Andreas Güenther

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Güenther. A scholar is included among the top collaborators of Andreas Güenther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Güenther. Andreas Güenther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guen, Pierre Le, Coralie Tardivon, Cédric Laouenan, et al.. (2023). Anti-mutated citrullinated vimentin antibodies are increased in IPF patients. Respiratory Medicine and Research. 85. 101081–101081. 1 indexed citations
2.
Chillappagari, Shashi, Andreas Güenther, & Poornima Mahavadi. (2023). BAG3: An enticing therapeutic target for idiopathic pulmonary fibrosis. Journal of Cellular Biochemistry. 125(11). e30446–e30446.
3.
Turkowski, Kati, Stefan Günther, Andreas Weigert, et al.. (2021). Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. Cancers. 13(2). 208–208. 15 indexed citations
4.
5.
Hengst, Meike, Lutz Naehrlich, Poornima Mahavadi, et al.. (2018). Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood. Orphanet Journal of Rare Diseases. 13(1). 42–42. 37 indexed citations
6.
Lehmann, Mareike, Olivier Burgy, Sarah Hermann, et al.. (2018). Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 198(12). 1527–1538. 140 indexed citations
7.
Ota, Chiharu, John-Poul Ng-Blichfeldt, Martina Korfei, et al.. (2018). Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis. Scientific Reports. 8(1). 12983–12983. 29 indexed citations
8.
White, Eric S., Zea Borok, Kevin M. Brown, et al.. (2016). An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research. American Journal of Respiratory and Critical Care Medicine. 193(7). 792–800. 19 indexed citations
9.
Korfei, Martina, Ingrid Henneke, BreAnne MacKenzie, et al.. (2015). Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. Thorax. 70(11). 1022–1032. 103 indexed citations
10.
Korfei, Martina, Ingrid Henneke, Daniel von der Beck, et al.. (2014). Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone. European Respiratory Journal. 44(Suppl 58). P736–P736. 1 indexed citations
11.
Ruppert, Clemens, et al.. (2014). Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis. European Respiratory Journal. 44(Suppl 58). P772–P772. 1 indexed citations
12.
Drakopanagiotakis, Fotios, Silke Tello, Daniel von der Beck, et al.. (2014). Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts. European Respiratory Journal. 44(Suppl 58). P762–P762. 1 indexed citations
13.
Wygrecka, Małgorzata, Grażyna Kwapiszewska, Ewa Jabłońska, et al.. (2011). Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 183(12). 1703–1714. 76 indexed citations
14.
Wygrecka, Małgorzata, Jochen Wilhelm, Ewa Jabłońska, et al.. (2011). Shedding of Low-Density Lipoprotein Receptor–related Protein-1 in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 184(4). 438–448. 39 indexed citations
15.
Markart, Philipp, Małgorzata Wygrecka, & Andreas Güenther. (2011). Update in Diffuse Parenchymal Lung Disease 2010. American Journal of Respiratory and Critical Care Medicine. 183(10). 1316–1321. 2 indexed citations
16.
Shetty, Sreerama, Yashodhar P. Bhandary, Shwetha K. Shetty, et al.. (2010). Induction of Tissue Factor by Urokinase in Lung Epithelial Cells and in the Lungs. American Journal of Respiratory and Critical Care Medicine. 181(12). 1355–1366. 18 indexed citations
17.
Mahavadi, Poornima, Martina Korfei, Ingrid Henneke, et al.. (2010). Epithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine. 182(2). 207–219. 71 indexed citations
18.
Dumitrascu, Rio, Soni Savai Pullamsetti, Hamza M. Al-tamari, et al.. (2010). Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine. 10(1). 26–26. 37 indexed citations
19.
Ramasamy, Suresh, Raghava Reddy, Jooeun Lee, et al.. (2009). Overexpression of Fibroblast Growth Factor-10 during Both Inflammatory and Fibrotic Phases Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice. American Journal of Respiratory and Critical Care Medicine. 180(5). 424–436. 97 indexed citations
20.
Korfei, Martina, Clemens Ruppert, Poornima Mahavadi, et al.. (2008). Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 178(8). 838–846. 388 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clemens Ruppert Breakdown of academic impact, for papers by Shwu‐Fan Ma Breakdown of academic impact, for papers by Dong‐Sheng Cheng Breakdown of academic impact, for papers by Naoki Hagimoto Breakdown of academic impact, for papers by Marjukka Myllärniemi Breakdown of academic impact, for papers by Brian B. Graham Breakdown of academic impact, for papers by Jean‐Jacques Lafitte Breakdown of academic impact, for papers by William D. Hardie Breakdown of academic impact, for papers by Susan H. Guttentag Breakdown of academic impact, for papers by Leigh M. Marsh
Rankless by CCL
2026